Skip to content
Grants Bay Logo
  • Home
  • Helpful Links
  • About
  • Contact Us
  • Privacy Policy
Previous Next

DoW Breast Cancer, Breakthrough Award Levels 1 and 2

Opportunity ID: 363670

General Information

Funding Opportunity Number HT942526BCRPBTA122
Funding Opportunity Title DoW Breast Cancer, Breakthrough Award Levels 1 and 2
Agency Danielle Reckley
Grantor
Document Type synopsis
Version 1
Opportunity Category Discretionary
Opportunity Category Explanation Not specified
Funding Instrument Type Grant
Category of Funding Activity Science and Technology and other Research and Development
Category Explanation Not specified
Expected Number of Awards 6
Cost Sharing or Matching Requirement No
Posted Date Sep 03, 2026 12:00:00 AM EDT
Last Updated Date Sep 03, 2026 08:38:01 AM EDT
Original Closing Date Nov 18, 2026 12:00:00 AM EST
Original Closing Date Notes Not specified
Current Closing Date Nov 18, 2026 12:00:00 AM EST
Current Closing Date Notes Not specified
Estimated Synopsis Date Not specified
Estimated Application Due Date Not specified
Estimated Award Date Not specified
Estimated Project Start Date Not specified
Archive Date Dec 18, 2026 12:00:00 AM EST
Estimated Total Program Funding 10,600,000
Award Ceiling none
Award Floor none

Assistance Listings

  • 12.420 — Military Medical Research and Development

Eligibility

Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

Description

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promising research with high potential to lead to or make breakthroughs in breast cancer. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception. Applications must address the challenge in a way that can lead to a breakthrough and have major impact. The FY26 Breakthrough Award mechanism contains four different funding levels designed to support major (but not all) stages of research that will lead to clinical application. Each level specifies a distinct research scope. This program announcement discusses the Breakthrough Award Levels 1 and 2.

Distinctive Features:

* This funding mechanism allows for applications submitted under Funding Level 1 or Funding Level 2. Funding Level 2 also includes a Population Science Studies option. With compelling justification, population science studies may request higher levels of funding and an additional year in the period of performance.

* This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI. For the Partnering PI Option (PPIO), only the Initiating PI will submit a pre-application, but both PIs will need to submit at the full application stage. Be advised, failure to submit all associated (Initiating and Partnering PI) applications by the deadline may result in administrative withdrawal.

Additional Information

Contact Danielle Reckley
Grantor
Contact Information eBRAP Help Desk
Phone: 301-682-5507
Email: help@eBRAP.org
Email help@eBRAP.org
Email Description eBRAP Help Desk
Phone 301-619-1139

Additional information

Version History

Version history

Opp hist id / Opportunity id 363670
Opp hist id / Revision 0
Opportunity id 363670
Revision 0
Opportunity number HT942526BCRPBTA122
Opportunity title DoW Breast Cancer, Breakthrough Award Levels 1 and 2
Owning agency code DOD-AMRAA
Opportunity category / Category D
Opportunity category / Description Discretionary
Forecast / Opp hist id / Opportunity id 363670
Forecast / Opp hist id / Revision 0
Forecast / Opportunity id 363670
Forecast / Revision 0
Forecast / Version 1
Forecast / Posting date Aug 20, 2026 12:00:00 AM EDT
Forecast / Forecast desc Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promising research with high potential to lead to or make breakthroughs in breast cancer. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception. Applications must address the challenge in a way that can lead to a breakthrough and have major impact. The FY26 Breakthrough Award mechanism contains four different funding levels designed to support major (but not all) stages of research that will lead to clinical application. Each level specifies a distinct research scope. This program announcement discusses the Breakthrough Award Levels 1 and 2.

Distinctive Features:

* This funding mechanism allows for applications submitted under Funding Level 1 or Funding Level 2. Funding Level 2 also includes a Population Science Studies option. With compelling justification, population science studies may request higher levels of funding and an additional year in the period of performance.

* This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI. For the Partnering PI Option (PPIO), only the Initiating PI will submit a pre-application, but both PIs will need to submit at the full application stage. Be advised, failure to submit all associated (Initiating and Partnering PI) applications by the deadline may result in administrative withdrawal.

Forecast / Cost sharing No
Forecast / Number of awards 6
Forecast / Estimated funding 10600000
Forecast / Award ceiling none
Forecast / Award floor none
Forecast / Agency contact name eBRAP Help Desk
Phone: 301-682-5507
Email: help@eBRAP.org
Forecast / Agency contact phone 301-682-5507
Forecast / Agency contact email help@eBRAP.org
Forecast / Agency contact email desc eBRAP Help Desk
Forecast / Agency code DOD-AMRAA
Forecast / Applicant eligibility desc Not specified
Forecast / Est synopsis posting date Sep 02, 2026 12:00:00 AM EDT
Forecast / Est application response date Nov 18, 2026 12:00:00 AM EST
Forecast / Est application response date desc Not specified
Forecast / Est award date Sep 30, 2027 12:00:00 AM EDT
Forecast / Est project start date Sep 30, 2027 12:00:00 AM EDT
Forecast / Fiscal year 2026
Forecast / Create time stamp Aug 20, 2026 10:54:18 AM EDT
Forecast / Action type U
Forecast / Action date Aug 20, 2026 11:05:11 AM EDT
Forecast / Created date Aug 20, 2026 09:13:45 AM EDT
Forecast / Last updated date Aug 20, 2026 10:54:18 AM EDT
Forecast / Agency details / Code AMRAA
Forecast / Agency details / Seed DOD-AMRAA
Forecast / Agency details / Agency name Defense Health Agency Contracting Activity – DHACA
Forecast / Agency details / Agency code DOD-AMRAA
Forecast / Agency details / Top agency code DOD
Forecast / Estimated funding formatted 10,600,000
Forecast / Applicant types 1 / Id 99
Forecast / Applicant types 1 / Description Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Forecast / Funding instruments 1 / Id G
Forecast / Funding instruments 1 / Description Grant
Forecast / Funding activity categories 1 / Id ST
Forecast / Funding activity categories 1 / Description Science and Technology and other Research and Development
Forecast / Posting date str 2026-08-20-00-00-00
Forecast / Est synopsis posting date str 2026-09-02-00-00-00
Forecast / Est application response date str 2026-11-18-00-00-00
Forecast / Est award date str 2027-09-30-00-00-00
Forecast / Est project start date str 2027-09-30-00-00-00
Forecast / Create time stamp str 2026-08-20-10-54-18
Cfdas 1 / Id 435160
Cfdas 1 / Opportunity id 363670
Cfdas 1 / Revision 1
Cfdas 1 / Cfda number 12.420
Cfdas 1 / Program title Military Medical Research and Development
Synopsis modified fields Not specified
Forecast modified fields Not specified
Opp hist id / Opportunity id 363670
Opp hist id / Revision 2
Opportunity id 363670
Revision 2
Opportunity number HT942526BCRPBTA122
Opportunity title DoW Breast Cancer, Breakthrough Award Levels 1 and 2
Owning agency code DOD-AMRAA
Opportunity category / Category D
Opportunity category / Description Discretionary
Forecast / Opp hist id / Opportunity id 363670
Forecast / Opp hist id / Revision 2
Forecast / Opportunity id 363670
Forecast / Revision 2
Forecast / Version 2
Forecast / Posting date Aug 20, 2026 12:00:00 AM EDT
Forecast / Forecast desc Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promising research with high potential to lead to or make breakthroughs in breast cancer. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception. Applications must address the challenge in a way that can lead to a breakthrough and have major impact. The FY26 Breakthrough Award mechanism contains four different funding levels designed to support major (but not all) stages of research that will lead to clinical application. Each level specifies a distinct research scope. This program announcement discusses the Breakthrough Award Levels 1 and 2.

Distinctive Features:

* This funding mechanism allows for applications submitted under Funding Level 1 or Funding Level 2. Funding Level 2 also includes a Population Science Studies option. With compelling justification, population science studies may request higher levels of funding and an additional year in the period of performance.

* This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI. For the Partnering PI Option (PPIO), only the Initiating PI will submit a pre-application, but both PIs will need to submit at the full application stage. Be advised, failure to submit all associated (Initiating and Partnering PI) applications by the deadline may result in administrative withdrawal.

Forecast / Cost sharing No
Forecast / Number of awards 6
Forecast / Estimated funding 10600000
Forecast / Award ceiling none
Forecast / Award floor none
Forecast / Agency contact name eBRAP Help Desk
Phone: 301-682-5507
Email: help@eBRAP.org
Forecast / Agency contact phone 301-682-5507
Forecast / Agency contact email help@eBRAP.org
Forecast / Agency contact email desc eBRAP Help Desk
Forecast / Agency code DOD-AMRAA
Forecast / Applicant eligibility desc Not specified
Forecast / Est synopsis posting date Sep 01, 2026 12:00:00 AM EDT
Forecast / Est application response date Nov 18, 2026 12:00:00 AM EST
Forecast / Est application response date desc Not specified
Forecast / Est award date Sep 30, 2027 12:00:00 AM EDT
Forecast / Est project start date Sep 30, 2027 12:00:00 AM EDT
Forecast / Fiscal year 2026
Forecast / Mod comments Revised Estimated Synopsis Post Date
Forecast / Create time stamp Aug 20, 2026 11:05:11 AM EDT
Forecast / Action type U
Forecast / Action date Sep 03, 2026 08:38:01 AM EDT
Forecast / Created date Aug 20, 2026 09:13:45 AM EDT
Forecast / Last updated date Aug 20, 2026 11:05:11 AM EDT
Forecast / Agency details / Code AMRAA
Forecast / Agency details / Seed DOD-AMRAA
Forecast / Agency details / Agency name Defense Health Agency Contracting Activity – DHACA
Forecast / Agency details / Agency code DOD-AMRAA
Forecast / Agency details / Top agency code DOD
Forecast / Estimated funding formatted 10,600,000
Forecast / Applicant types 1 / Id 99
Forecast / Applicant types 1 / Description Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Forecast / Funding instruments 1 / Id G
Forecast / Funding instruments 1 / Description Grant
Forecast / Funding activity categories 1 / Id ST
Forecast / Funding activity categories 1 / Description Science and Technology and other Research and Development
Forecast / Posting date str 2026-08-20-00-00-00
Forecast / Est synopsis posting date str 2026-09-01-00-00-00
Forecast / Est application response date str 2026-11-18-00-00-00
Forecast / Est award date str 2027-09-30-00-00-00
Forecast / Est project start date str 2027-09-30-00-00-00
Forecast / Create time stamp str 2026-08-20-11-05-11
Cfdas 1 / Id 435160
Cfdas 1 / Opportunity id 363670
Cfdas 1 / Revision 1
Cfdas 1 / Cfda number 12.420
Cfdas 1 / Program title Military Medical Research and Development
Synopsis modified fields Not specified
Forecast modified fields revision; version; estSynopsisPostingDate; modComments

Forecast changes

revision

version

sendEmail

archiveDate

modComments

createTimeStamp

Id 363670
Revision 3
Opportunity number HT942526BCRPBTA122
Opportunity title DoW Breast Cancer, Breakthrough Award Levels 1 and 2
Owning agency code DOD-AMRAA
Opportunity category / Category D
Opportunity category / Description Discretionary
Synopsis / Opportunity id 363670
Synopsis / Version 1
Synopsis / Agency code DOD-AMRAA
Synopsis / Agency name Danielle Reckley
Grantor
Synopsis / Agency phone 301-619-1139
Synopsis / Agency address desc eBRAP Help Desk
Synopsis / Agency details / Code AMRAA
Synopsis / Agency details / Seed DOD-AMRAA
Synopsis / Agency details / Agency name Defense Health Agency Contracting Activity – DHACA
Synopsis / Agency details / Agency code DOD-AMRAA
Synopsis / Agency details / Top agency code DOD
Synopsis / Top agency details / Code DOD
Synopsis / Top agency details / Seed DOD
Synopsis / Top agency details / Agency name Department of Defense
Synopsis / Top agency details / Agency code DOD
Synopsis / Top agency details / Top agency code DOD
Synopsis / Agency contact phone 301-619-1139
Synopsis / Agency contact name Danielle Reckley
Grantor
Synopsis / Agency contact desc eBRAP Help Desk
Phone: 301-682-5507
Email: help@eBRAP.org
Synopsis / Agency contact email help@eBRAP.org
Synopsis / Agency contact email desc eBRAP Help Desk
Synopsis / Synopsis desc Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promising research with high potential to lead to or make breakthroughs in breast cancer. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception. Applications must address the challenge in a way that can lead to a breakthrough and have major impact. The FY26 Breakthrough Award mechanism contains four different funding levels designed to support major (but not all) stages of research that will lead to clinical application. Each level specifies a distinct research scope. This program announcement discusses the Breakthrough Award Levels 1 and 2.

Distinctive Features:

* This funding mechanism allows for applications submitted under Funding Level 1 or Funding Level 2. Funding Level 2 also includes a Population Science Studies option. With compelling justification, population science studies may request higher levels of funding and an additional year in the period of performance.

* This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI. For the Partnering PI Option (PPIO), only the Initiating PI will submit a pre-application, but both PIs will need to submit at the full application stage. Be advised, failure to submit all associated (Initiating and Partnering PI) applications by the deadline may result in administrative withdrawal.

Synopsis / Response date Nov 18, 2026 12:00:00 AM EST
Synopsis / Response date desc Not specified
Synopsis / Posting date Sep 03, 2026 12:00:00 AM EDT
Synopsis / Archive date Dec 18, 2026 12:00:00 AM EST
Synopsis / Cost sharing No
Synopsis / Number of awards 6
Synopsis / Estimated funding 10600000
Synopsis / Estimated funding formatted 10,600,000
Synopsis / Award ceiling none
Synopsis / Award floor none
Synopsis / Applicant eligibility desc Not specified
Synopsis / Create time stamp Sep 03, 2026 08:41:10 AM EDT
Synopsis / Created date Sep 03, 2026 08:38:01 AM EDT
Synopsis / Last updated date Sep 03, 2026 08:38:01 AM EDT
Synopsis / Applicant types 1 / Id 99
Synopsis / Applicant types 1 / Description Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Synopsis / Funding instruments 1 / Id G
Synopsis / Funding instruments 1 / Description Grant
Synopsis / Funding activity categories 1 / Id ST
Synopsis / Funding activity categories 1 / Description Science and Technology and other Research and Development
Synopsis / Response date str 2026-11-18-00-00-00
Synopsis / Posting date str 2026-09-03-00-00-00
Synopsis / Archive date str 2026-12-18-00-00-00
Synopsis / Create time stamp str 2026-09-03-08-41-10
Agency details / Code AMRAA
Agency details / Seed DOD-AMRAA
Agency details / Agency name Defense Health Agency Contracting Activity – DHACA
Agency details / Agency code DOD-AMRAA
Agency details / Top agency code DOD
Top agency details / Code DOD
Top agency details / Seed DOD
Top agency details / Agency name Department of Defense
Top agency details / Agency code DOD
Top agency details / Top agency code DOD
Forecast / Opportunity id 363670
Forecast / Version 3
Forecast / Posting date Aug 20, 2026 12:00:00 AM EDT
Forecast / Archive date Sep 02, 2026 12:00:00 AM EDT
Forecast / Forecast desc Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promising research with high potential to lead to or make breakthroughs in breast cancer. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception. Applications must address the challenge in a way that can lead to a breakthrough and have major impact. The FY26 Breakthrough Award mechanism contains four different funding levels designed to support major (but not all) stages of research that will lead to clinical application. Each level specifies a distinct research scope. This program announcement discusses the Breakthrough Award Levels 1 and 2.

Distinctive Features:

* This funding mechanism allows for applications submitted under Funding Level 1 or Funding Level 2. Funding Level 2 also includes a Population Science Studies option. With compelling justification, population science studies may request higher levels of funding and an additional year in the period of performance.

* This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI. For the Partnering PI Option (PPIO), only the Initiating PI will submit a pre-application, but both PIs will need to submit at the full application stage. Be advised, failure to submit all associated (Initiating and Partnering PI) applications by the deadline may result in administrative withdrawal.

Forecast / Cost sharing No
Forecast / Number of awards 6
Forecast / Estimated funding 10600000
Forecast / Award ceiling none
Forecast / Award floor none
Forecast / Agency contact name eBRAP Help Desk
Phone: 301-682-5507
Email: help@eBRAP.org
Forecast / Agency contact phone 301-682-5507
Forecast / Agency contact email help@eBRAP.org
Forecast / Agency contact email desc eBRAP Help Desk
Forecast / Agency code DOD-AMRAA
Forecast / Applicant eligibility desc Not specified
Forecast / Est synopsis posting date Sep 01, 2026 12:00:00 AM EDT
Forecast / Est application response date Nov 18, 2026 12:00:00 AM EST
Forecast / Est application response date desc Not specified
Forecast / Est award date Sep 30, 2027 12:00:00 AM EDT
Forecast / Est project start date Sep 30, 2027 12:00:00 AM EDT
Forecast / Fiscal year 2026
Forecast / Mod comments Updated Archive Date
Forecast / Create time stamp Sep 03, 2026 08:41:10 AM EDT
Forecast / Created date Aug 20, 2026 09:13:45 AM EDT
Forecast / Last updated date Sep 03, 2026 08:41:10 AM EDT
Forecast / Agency details / Code AMRAA
Forecast / Agency details / Seed DOD-AMRAA
Forecast / Agency details / Agency name Defense Health Agency Contracting Activity – DHACA
Forecast / Agency details / Agency code DOD-AMRAA
Forecast / Agency details / Top agency code DOD
Forecast / Estimated funding formatted 10,600,000
Forecast / Applicant types 1 / Id 99
Forecast / Applicant types 1 / Description Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Forecast / Funding instruments 1 / Id G
Forecast / Funding instruments 1 / Description Grant
Forecast / Funding activity categories 1 / Id ST
Forecast / Funding activity categories 1 / Description Science and Technology and other Research and Development
Forecast / Posting date str 2026-08-20-00-00-00
Forecast / Archive date str 2026-09-02-00-00-00
Forecast / Est synopsis posting date str 2026-09-01-00-00-00
Forecast / Est application response date str 2026-11-18-00-00-00
Forecast / Est award date str 2027-09-30-00-00-00
Forecast / Est project start date str 2027-09-30-00-00-00
Forecast / Create time stamp str 2026-09-03-08-41-10
Synopsis attachment folders 1 / Id 81257
Synopsis attachment folders 1 / Opportunity id 363670
Synopsis attachment folders 1 / Folder type Full Announcement
Synopsis attachment folders 1 / Folder name FY26 BCRP BTA122
Synopsis attachment folders 1 / Zip lob size 562795
Synopsis attachment folders 1 / Created date Sep 03, 2026 08:39:51 AM EDT
Synopsis attachment folders 1 / Last updated date Sep 03, 2026 08:41:10 AM EDT
Synopsis attachment folders 1 / Synopsis attachments 1 / Id 354968
Synopsis attachment folders 1 / Synopsis attachments 1 / Opportunity id 363670
Synopsis attachment folders 1 / Synopsis attachments 1 / Mime type application/pdf
Synopsis attachment folders 1 / Synopsis attachments 1 / File name HT942526BCRPBTA122_GG.pdf
Synopsis attachment folders 1 / Synopsis attachments 1 / File description FY26 BCRP BTA122 Program Announcement
Synopsis attachment folders 1 / Synopsis attachments 1 / File lob size 722039
Synopsis attachment folders 1 / Synopsis attachments 1 / Created date Sep 03, 2026 08:41:10 AM EDT
Synopsis attachment folders 1 / Synopsis attachments 1 / Synopsis att folder id 81257
Synopsis document urls Not specified
Syn att change comments Not specified
Cfdas 1 / Id 435160
Cfdas 1 / Opportunity id 363670
Cfdas 1 / Cfda number 12.420
Cfdas 1 / Program title Military Medical Research and Development
Opportunity pkgs 1 / Id 294130
Opportunity pkgs 1 / Topportunity id 363670
Opportunity pkgs 1 / Family id 14
Opportunity pkgs 1 / Dialect XFDL2.2
Opportunity pkgs 1 / Opportunity number HT942526BCRPBTA122
Opportunity pkgs 1 / Opportunity title DoW Breast Cancer, Breakthrough Award Levels 1 and 2
Opportunity pkgs 1 / Cfda number 12.420
Opportunity pkgs 1 / Opening date 2026-09-03
Opportunity pkgs 1 / Closing date 2026-11-18
Opportunity pkgs 1 / Owning agency code DOD-AMRAA
Opportunity pkgs 1 / Agency details / Code AMRAA
Opportunity pkgs 1 / Agency details / Seed DOD-AMRAA
Opportunity pkgs 1 / Agency details / Agency name Defense Health Agency Contracting Activity – DHACA
Opportunity pkgs 1 / Agency details / Agency code DOD-AMRAA
Opportunity pkgs 1 / Agency details / Top agency code DOD
Opportunity pkgs 1 / Top agency details / Code DOD
Opportunity pkgs 1 / Top agency details / Seed DOD
Opportunity pkgs 1 / Top agency details / Agency name Department of Defense
Opportunity pkgs 1 / Top agency details / Agency code DOD
Opportunity pkgs 1 / Top agency details / Top agency code DOD
Opportunity pkgs 1 / Program title Military Medical Research and Development
Opportunity pkgs 1 / Contact info eBRAP Help Desk
Phone: 301-682-5507
Email: help@eBRAP.org
Opportunity pkgs 1 / Grace period 0
Opportunity pkgs 1 / Electronic required Y
Opportunity pkgs 1 / Expected application count 350
Opportunity pkgs 1 / Expected application size 1000000
Opportunity pkgs 1 / Open to applicant type 1
Opportunity pkgs 1 / Is multi project N
Opportunity pkgs 1 / Extension pdf
Opportunity pkgs 1 / Mimetype application/pdf
Opportunity pkgs 1 / Last update Sep 03, 2026 08:52:47 AM EDT
Opportunity pkgs 1 / Workspace compatible flag Y
Opportunity pkgs 1 / Package id PKG00294130
Opportunity pkgs 1 / Opening date str 2026-09-03-00-00-00
Opportunity pkgs 1 / Closing date str 2026-11-18-00-00-00
Closed opportunity pkgs Not specified
Original due date Nov 18, 2026 12:00:00 AM EST
Original due date desc Not specified
Synopsis modified fields Not specified
Forecast modified fields revision; version; sendEmail; archiveDate; modComments; createTimeStamp
Error messages Not specified
Syn post date in past Yes
Doc type synopsis
Forecast hist count 2
Synopsis hist count 0
Assist compatible No
Assist url Not specified
Related opps Not specified
Ost POSTED

Related Documents

HT942526BCRPBTA122_GG.pdf

Packages

Agency Contact Information: eBRAP Help Desk
Phone: 301-682-5507
Email: help@eBRAP.org
Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
12.420 PKG00294130 2026-09-03 2026-11-18 View

Package 1

Instructions

PKG00294130-instructions.pdf

Mandatory forms

RR_SF424_5_0-V5.0.pdf
AttachmentForm_1_2-V1.2.pdf
RR_KeyPersonExpanded_4_0-V4.0.pdf
RR_Budget_3_0-V3.0.pdf
PerformanceSite_4_0-V4.0.pdf

Optional forms

RR_SubawardBudget30_3_0-V3.0.pdf

osnqt2026-09-15T23:19:33-05:00

Share This Post, Choose Your Platform!

XLinkedIn

About the Author: osnqt

Copyright 2012 - 2025 | All Rights Reserved
Page load link
Go to Top